Liver transplant biopsy study using TruGraf
Part of Immune system & allergy clinical trials.
This study uses a blood test called TruGraf to check for liver transplant problems. It may help diagnose issues without a biopsy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You received a single-organ liver transplant (only a liver, no other organs).
- You are 18 years or older.
- You are willing and able to give your consent.
- You are scheduled for a liver biopsy or had one within the last 48 hours.
- You have not received treatment for rejection (like IV steroids) before the biopsy.
- The biopsy is not being done to check for cancer.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how well a new blood test works to monitor kidney health after a transplant. It might help doctors catch problems early without needing a biopsy.
This study tests whether a small biopsy taken from a donor heart before transplant can predict how well the heart will work after surgery. The goal is to improve transplant success for recipients.
This study looks at whether genetic testing of a tissue sample (biopsy) can help doctors more accurately diagnose rejection after a liver transplant. It is for people who have already been diagnosed with rejection and have a stored tissue sample available.
This study checks whether a special blood test can predict who is at higher risk of graft loss (the transplanted liver not working well) and death after a liver transplant. It may help doctors identify higher-risk patients earlier and tailor follow-up care.
This trial uses DNA testing and gene expression profiling to see if kidney transplant recipients can safely switch to a belatacept-only immunosuppression regimen. The goal is to simplify your anti-rejection drugs while keeping your kidney healthy.
This study looks at using a special lab test (microarrays) on tissue taken during a lung transplant biopsy. It aims to learn how the test may help doctors better diagnose and guide care after transplant.
Hear when a new Acute Graft Rejection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.